Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic
- 16 August 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 389 (10), 1133-1137
- https://doi.org/10.1007/s00210-016-1286-7
Abstract
Loperamide is a μ-opioid receptor agonist commonly used to treat diarrhea and often available as an over-the-counter medication. Recently, numerous reports of QRS widening accompanied by dramatic QT interval prolongation, torsades de pointe arrhythmia, and death have been reported in opioid abusers consuming large amounts of the drug to produce euphoria or prevent opiate withdrawal. The present study was undertaken to determine the mechanisms of this cardiotoxicity. Using whole-cell patch clamp electrophysiology, we tested loperamide on the cloned human cardiac sodium channel (Nav1.5) and the two main repolarizing cardiac K+ channels cloned from the human heart: KvLQT1/minK and the human ether-a-go-go-related gene (hERG) channel. Loperamide inhibited Nav1.5 with IC50 values of 297 and 239 nM at holding potentials of −90 and −70 mV, respectively. Loperamide was weakly active on KvLQT1/minK producing 17 and 65 % inhibition at concentrations of 1 and 10 μM, respectively. Conversely, loperamide was found to be a very high affinity inhibitor of the hERG channel with an IC50 value of 89 nM at room temperature and 33 nM when measured at physiological temperature. The QRS and QT interval prolongation and the attending arrhythmias, produced by loperamide, derive from high affinity inhibition of Nav1.5 and especially hERG. Since the drug has been widely available and safely used as directed for many years, we believe that the potent inhibition loperamide possesses for cardiac ion channels has only been uncovered because of the excessive misuse of the drug as a consequence of the recent opioid abuse epidemic.Keywords
This publication has 24 references indexed in Scilit:
- A history of the role of the hERG channel in cardiac risk assessmentJournal of Pharmacological and Toxicological Methods, 2013
- LoperamideJournal of Pain and Symptom Management, 2011
- On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complexBritish Journal of Pharmacology, 2011
- DrugBank: a comprehensive resource for in silico drug discovery and explorationNucleic Acids Research, 2006
- Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus patternJournal of Pharmacological and Toxicological Methods, 2004
- Understanding the Structure−Activity Relationship of the Human Ether-a-go-go-Related Gene Cardiac K+ Channel. A Model for Bad BehaviorJournal of Medicinal Chemistry, 2003
- KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium currentNature, 1996
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- Terfenadine-Ketoconazole InteractionJAMA, 1993
- Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.Proceedings of the National Academy of Sciences of the United States of America, 1992